---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-046719"
form_type: "8-K"
ticker: "APRE"
cik: "0001781983"
company_name: "Aprea Therapeutics, Inc."
filed_at: "2023-04-18T23:59:59+00:00"
generated_at: "2026-06-17T00:49:17.192771+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Aprea Therapeutics dismisses EY, appoints EisnerAmper as new independent auditor

## Summary
- On April 17, 2023, Aprea dismissed Ernst & Young LLP as its independent auditor, effective immediately.
- The Audit Committee approved the dismissal and engagement of EisnerAmper LLP as new auditor for FY 2023.
- EY's reports for 2022 and 2021 contained no adverse opinion or qualification; no disagreements or reportable events existed.
- No consultations with EisnerAmper occurred prior to engagement on any accounting matters.

## SEC filing metadata
- accession: 0001104659-23-046719
- form_type: 8-K
- ticker: APRE
- cik: 0001781983
- company_name: Aprea Therapeutics, Inc.
- filed_at: 2023-04-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781983/000110465923046719/0001104659-23-046719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781983/000110465923046719/tm2312947d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-046719
- JSON: https://secwatch.observer/filing/0001104659-23-046719.json
- Plain text: https://secwatch.observer/filing/0001104659-23-046719.txt

## Key facts
- Auditor Changes
  Aprea Therapeutics, Inc. dismissed Ernst & Young LLP as its auditor.
  - Action: dismissal
  - Auditor: Ernst & Young LLP
  - Successor: EisnerAmper LLP
  source text: On April 17, 2023, Aprea Therapeutics, Inc. (the “Company”) dismissed Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1781983/000110465923046719/0001104659-23-046719-index.htm
- Auditor Changes
  Aprea Therapeutics, Inc. engaged EisnerAmper LLP as its auditor.
  - Action: engagement
  - Auditor: EisnerAmper LLP
  source text: On April 17, 2023, in connection with the Company’s dismissal of EY, the Company engaged EisnerAmper LLP (“EisnerAmper”) as its new independent registered public accounting firm to audit the Company’s financial statements for the year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1781983/000110465923046719/0001104659-23-046719-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.